These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12901797

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Curcumin inhibits WT1 gene expression in human leukemic K562 cells.
    Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Chanarat P, Limtrakul P.
    Acta Pharmacol Sin; 2006 Mar; 27(3):360-6. PubMed ID: 16490174
    [Abstract] [Full Text] [Related]

  • 24. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
    Shibata R, Takata A, Hashiguchi A, Umezawa A, Yamada T, Hata J.
    Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome.
    Bergmann L, Miething C, Maurer U, Brieger J, Karakas T, Weidmann E, Hoelzer D.
    Blood; 1997 Aug 01; 90(3):1217-25. PubMed ID: 9242555
    [Abstract] [Full Text] [Related]

  • 27. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z, Merino MJ, Vortmeyer AO, Bryant B, Lash AE, Wang C, Deavers MT, Shelton WF, Kapur S, Chandra RS.
    J Natl Cancer Inst; 1997 Aug 06; 89(15):1148-52. PubMed ID: 9262253
    [Abstract] [Full Text] [Related]

  • 28. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H, Shen Y, Sun N, Jiang YP, Li ML, Sun L.
    Chin Med J (Engl); 2012 May 06; 125(10):1733-9. PubMed ID: 22800892
    [Abstract] [Full Text] [Related]

  • 29. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM, Kim CE, Margolin AA, Guo M, Zhu J, Mason JM, Hensle TW, Murty VV, Grundy PE, Fearon ER, D'Agati V, Licht JD, Tycko B.
    Am J Pathol; 2004 Dec 06; 165(6):1943-53. PubMed ID: 15579438
    [Abstract] [Full Text] [Related]

  • 30. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
    Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJ, Pass HI, Kari C, Rodeck U, Rauscher FJ.
    Am J Pathol; 1995 Feb 06; 146(2):344-56. PubMed ID: 7856747
    [Abstract] [Full Text] [Related]

  • 31. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X, Wang Y, Gao N, Wang J.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 06; 43(2):77-82. PubMed ID: 24742565
    [Abstract] [Full Text] [Related]

  • 32. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
    Jiang YP, Shen Y, Sun N, Wang H.
    Zhonghua Er Ke Za Zhi; 2009 Oct 06; 47(10):762-6. PubMed ID: 20021811
    [Abstract] [Full Text] [Related]

  • 33. Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias.
    Siehl JM, Thiel E, Heufelder K, Snarski E, Schwartz S, Mailänder V, Keilholz U.
    Br J Haematol; 2003 Oct 06; 123(2):235-42. PubMed ID: 14531904
    [Abstract] [Full Text] [Related]

  • 34. Inhibitory effect of curcumin on WT1 gene expression in patient leukemic cells.
    Anuchapreeda S, Limtrakul P, Thanarattanakorn P, Sittipreechacharn S, Chanarat P.
    Arch Pharm Res; 2006 Jan 06; 29(1):80-7. PubMed ID: 16491848
    [Abstract] [Full Text] [Related]

  • 35. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells.
    Koesters R, Linnebacher M, Coy JF, Germann A, Schwitalle Y, Findeisen P, von Knebel Doeberitz M.
    Int J Cancer; 2004 Apr 10; 109(3):385-92. PubMed ID: 14961577
    [Abstract] [Full Text] [Related]

  • 36. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
    Glienke W, Maute L, Wicht J, Bergmann L.
    Eur J Cancer; 2009 Mar 10; 45(5):874-80. PubMed ID: 19196508
    [Abstract] [Full Text] [Related]

  • 37. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF.
    J Natl Cancer Inst; 1992 Feb 05; 84(3):181-7. PubMed ID: 1311774
    [Abstract] [Full Text] [Related]

  • 38. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
    Ullmark T, Montano G, Järvstråt L, Jernmark Nilsson H, Håkansson E, Drott K, Nilsson B, Vidovic K, Gullberg U.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):802-807. PubMed ID: 27889611
    [Abstract] [Full Text] [Related]

  • 39. The role of WT1 gene in neuroblastoma.
    Wang J, Oue T, Uehara S, Yamanaka H, Oji Y, Fukuzawa M.
    J Pediatr Surg; 2011 Feb 22; 46(2):326-31. PubMed ID: 21292082
    [Abstract] [Full Text] [Related]

  • 40. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L, Kalinova M, Ryan J, Quinn F, O'Marcaigh A, Smith O, Browne P, Stary J, McCann SR, Trka J, Lawler M.
    Leukemia; 2006 Feb 22; 20(2):254-63. PubMed ID: 16341043
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.